Comparative Pharmacology
Head-to-head clinical analysis: POTASSIUM CHLORIDE versus POTASSIUM CHLORIDE 0 037 IN DEXTROSE 5 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: POTASSIUM CHLORIDE versus POTASSIUM CHLORIDE 0 037 IN DEXTROSE 5 IN PLASTIC CONTAINER.
POTASSIUM CHLORIDE vs POTASSIUM CHLORIDE 0.037% IN DEXTROSE 5% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Potassium is the major intracellular cation. It is essential for the maintenance of intracellular tonicity, transmission of nerve impulses, contraction of cardiac, skeletal, and smooth muscle, and maintenance of normal renal function. Potassium chloride dissociates to provide potassium ions and chloride ions. Potassium repletion corrects hypokalemia and associated disorders.
Potassium chloride dissociates to provide potassium ions, which are essential for maintaining intracellular osmolarity, acid-base balance, and normal nerve conduction and muscle contraction, including cardiac muscle. Dextrose provides a source of calories and may prevent ketosis.
Oral: 40-100 mEq/day in divided doses; IV: up to 10-20 mEq/hour via central line, max 40 mEq/hour with continuous monitoring; not to exceed 200 mEq/day.
Intravenous infusion of potassium chloride 0.037% in dextrose 5% at a rate not exceeding 10 mEq/hour of potassium and a maximum concentration of 40 mEq/L in peripheral veins; dose determined by serum potassium level and clinical need, typically 20-40 mEq per day for mild depletion.
None Documented
None Documented
Clinical Note
moderateQuinidine + Potassium chloride
"Quinidine may increase the ulcerogenic activities of Potassium chloride."
Clinical Note
moderateTrimethaphan + Potassium chloride
"Trimethaphan may increase the ulcerogenic activities of Potassium chloride."
Clinical Note
moderateMecamylamine + Potassium chloride
"Mecamylamine may increase the ulcerogenic activities of Potassium chloride."
Clinical Note
moderateAtracurium besylate + Potassium chloride
Not applicable; potassium is an electrolyte regulated by homeostasis, not classic elimination half-life. Under normal renal function, serum half-life of administered potassium is approximately 2-4 hours due to rapid cellular uptake and renal excretion.
Potassium has a complex disposition; the distribution between intracellular and extracellular compartments affects half-life. In normal renal function, the serum potassium half-life is approximately 4-6 hours after a dose, but this is not a true terminal half-life due to extensive tissue buffering. The body's total potassium turnover half-life is around 25-30 hours. In patients with renal impairment, half-life is prolonged proportionally to creatinine clearance.
Primarily renal (90%) as potassium ion; minimal fecal (<10%) and sweat.
Potassium is primarily excreted renally (>90%) with about 10% excreted in feces via gastrointestinal secretion. Minimal excretion occurs through sweat. Renal handling involves glomerular filtration, proximal tubular reabsorption, and potassium secretion in the distal tubule and collecting duct regulated by aldosterone. Excretion is not linear and depends on potassium balance, renal function, and hormonal influences.
Category C
Category C
Electrolyte Supplement
Electrolyte Supplement
"Atracurium besylate may increase the ulcerogenic activities of Potassium chloride."